Dysthyroidism in Chronic Hemodialysis Patients

Authors

  • Ikram Benmakhlouf Biochemistry laboratory, University Hospital Centre Ibn Rochd, Casablanca, Morocco
  • Essaidi Imane Biochemistry laboratory, University Hospital Centre Ibn Rochd, Casablanca, Morocco
  • Mohammed Benghanem Gharbi Nephrology Department , University Hospital Centre Ibn Rochd, Casablanca, Morocco, Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco
  • Asmaa Morjan Biochemistry laboratory, University Hospital Centre Ibn Rochd, Casablanca, Morocco ,Laboratory of Clinical Immunology and Immuno-Allergy (LICIA), Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco
  • Nabiha Kamal Biochemistry laboratory, University Hospital Centre Ibn Rochd, Casablanca, Morocco ,Laboratory of Clinical Immunology and Immuno-Allergy (LICIA), Faculty of Medicine and Pharmacy, Hassan II University, Casablanca, Morocco

DOI:

https://doi.org/10.55677/IJCSMR/V5I1-07/2025

Keywords:

Dysthyroidism, chronic hemodialysis

Abstract

Objective: The purpose of this study is to investigate the thyroid profile in HDC in order to determine prevalence and incidence, and to identify factors favouring each thyroid disorder.

Methods: This is a retrospective study spread over an 8-month period from January to August 2024, based on the exploitation of hospital records of adult patients on chronic hemodialysis. Biological results were collated from computerized data from the Biochemistry Laboratory.

Results: Nearly 36% of patients presented with anemia.Phosphocalcic disorders were dominated by hyperparathyroidism, mean calcemia 89.25 mg/l , mean phosphoremia 37.3 mg/l with high PAL . CRP varied between 0 and 60mg/l. TSH varied between 0.01 and 10.8 mIU/L. Hormone assays revealed hypothyroidism in 15 patients, representing an estimated prevalence of 25%.  FT3 was low in 11 patients, with a mean of 1 ± 0.26 ng/l. 3 patients had both low FT3 and low FT4, with a mean FT4 of 0.5 ± 1 ng/l. 1 hemodialysis patient had a very high TSHus (TSHus = 11mUI/l).

Conclusion: Inflammatory syndrome, nutritional status, advanced age and long duration of hemodialysis are risk factors for dysthyroidism. Systematic screening for thyroid disorders in HDC patients should be carried out by means of biological tests (TSHus,T3L,T4L), and strict annual follow-up is essential.

References

Kaptein EM. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocrine Reviews. 1996;7:45–63. [PubMed] [Google Scholar]

Zoccali C, Tripepi G, Cutrupi S, Pizzini P, Mallamaci F. Low triiodothyronine: a newfacet of inflammation in endstage renal disease. J Am Soc Nephrol. 2005;6:2789–95. [PubMed] [Google Scholar]

Zoccali C, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P. Low triiodothyronine and survival in end-stage renal disease. Kidney Int. 2006;70:523–8. [PubMed]

M.Ponsoye,R.Paule,V.Gueutin,G.Deray,H.Izzedine Kidney and thyroid dysfunction.Néphrologie and thérapeutique 2013 ,13-20

P Iglesias ,J J Diez .Thyroid dysfunction and kidney disease. European Journalof Endocrinology 2009,160 503-515

VS.Lim. Thyroid function in patients with chronic renal failure. American Journal of Kidney Diseases,October 2001,80-84

Kaptein EM. Thyroid hormone metabolism and thyroid diseases in chronic renal failure. Endocrine Reviews. 1996 ; 7 : 45-63

PM Kar,A Hirani , MJ Allen. Acute renal failure in a hypothroid patient with rhabdomyolisis. Clinical Nephrology. 2003 ; 60 : 428-9

Lucal, B.Goichot, T .Brue. Les dyshormonémies des affections non thyroidiennes. Annales d’Endocrinologie 71 ,2010 :S13-S24.

MF. Slag, JE. Morley, MK.Elson, TW.Crowson, FQ.Nuttall, RB.Shafer. Hypothyroxinemia in critically ill patients as a predictor of high mortality. JAMA 1981 ;245 ;43-5.

Fliers E , Alkemade A , Wiersinga WM. The hypothalamic-pituitary-thyroid axis in Critical illness ;Best practice and research. Clinical endocrinology and metabolism 2001 ;15 ;453-64

SV. Lim , M.Suneja. Thyroid status in chronic renal failure patients –A non- Throidal illness syndrome. Am J Kidney Dis.2001 Oct ;38(4suppl 1) :S80-4.

I.Wartofsky, KD.Burman. Altérations in thyroid function in patients with systemic illness : the « euthyroid sick syndrome ». Endocr Rev 1982 ;3 :164-217.

EM. Kaptein, D. Levitan,El.Feinstein,JT. Nicoloff,SG. Massry. Alterations of thyroid hormone indices in acute renal failure and in acute critical illness with and without acute renal failure. Am Journal Nephrol 1981 ;1 :138-43

MR. Wiederkehr,J.Kalogiros ,R.Krapf. Correction of metabolic acidosis improves thyroid and growth hormone axes in haemodialysis patients. Nephrol Dial Transplant 2004 ;19 :1190.

SW. Splauding,RI . Gregermen. Free thyroxine in serumby equilibrium dialysis :Effects of dilution,specific ions and inhibitors of binding. J Clin Endocrinol Metab 1972 ;34 :974.

Boelen A. A causal role of IL-6 in the development of the low T3 syndrome. Endocrinology.

;37:5250–4. [PubMed] [Google Scholar]

Stenvinkel P. Elevated serum levels of soluble adhesion molecules predict death in pre-dialysis patient: association with malnutrition, inflammation, and cardiovascular disease. Nephrol Dial Transplant. 2000;5:624-30. [PubMed] [Google Scholar]

Carrero JJ, Qureshi AR, Axelsson J, Yilmaz MI, Rehnmark S, Witt MR. et al. Clinical and biochemical implications of low thyroid hormone levels (total and free forms) in euthyroid patients with chronic kidney disease. J Intern Med. 2007;262

Walsh JP, Bremner AP, Bulsara MK, O'Leary P, Leedman PJ, Feddema . Subclinical thyroid dysfunction as a risk factor for cardiovascular disease. Arch Intern Med. 2005 Nov28;65(2):2467–72. [PubMed] [Google Scholar]

Zoccali C, Benedetto F, Mallamaci F, Tripepi G, Cutrupi S, Pizzini P. et al. Low triiodothyronine and cardiomyopathy in patients with endstage renal disease. JHypertens. 2006;24:2039–46. [PubMed] [Google Scholar]

Enia G, Panuccio V, Cutrupi S, Pizzini P, Tripepi G, Mallamaci F, Zoccali C. Subclinical hypothyroidism is linked to micro-inflammation and predicts death in Continuous ambulatory peritoneal dialysis. Nephrol Dial Transplant. 2007 Feb;22(2):538–44. Epub 2006 Nov 2. [PubMed] [Google Scholar]

Chen HS, Wu TE, Jap TS, Lu RA, Wang ML, Chen RL. et al. Subclinical hypothyroidism is a risk factor for nephropathy and cardiovascular diseases in type 2 diabetic patients. Diabet Med. 2007;24:336–44. [PubMed] [Google Scholar]

JC. Lo, GM. Chertow, AS.Go, CY Hsu. Increased prevalence of subclinical and clinical . hypothyroidism in persons with chronic kidney disease. Kidney int. 2005 ;67 :047-52

AD.Spector, JP.Davis , F.A.C.P. ;JH .Helderman,B.Bell ,RD.Utiger. Thyroid Function And Metabolic State in Chronic Renal Failure. Ann Intern Med. 1976 ;85(6) :724-730.

J.Malyszko, JS.Malyszko, K. Pawlak, M.Mysliwiec. Thyroid function, endothelium ,And inflammation in hemodialyzed patients :possible relations ? Journal of Renal Nutrition.2007 ;7 :30-7

C.Zoccali, F.Mallamaci, G.Tripepi, S.Cutrupi, P. Pizzini. Low triiodothyonine and survival in end-stage renal disease. Kidney Int. 2006 ; 70 : 523-8.

IJ.Chopra. Euthyroid Sick Syndrome :Is It a Misnomer ? Jornal of Clinical Endocrinology and Metabolism. 1997 :82.

Downloads

Published

2025-01-29

How to Cite

Benmakhlouf, I., Imane, E., Gharbi, M. B., Morjan, A., & Kamal, N. (2025). Dysthyroidism in Chronic Hemodialysis Patients. International Journal of Clinical Science and Medical Research, 5(01), 39–44. https://doi.org/10.55677/IJCSMR/V5I1-07/2025